Navigation Links
KellBenx Secures $2.5 Million Funding Round
Date:4/21/2011

NEW YORK, April 21, 2011 /PRNewswire/ -- KellBenx, a biotechnology company focused on the development of non-invasive prenatal diagnosis (NIPD) of genetic and inherited disorders, announced today that it has secured an initial funding round of $2.5 million from four investors –  three biotechnology venture capital groups and one angel investor. The round will finance a clinical trial and laboratory testing of a new, minimally invasive blood test designed to identify risks to pregnancy ranging from pre-term birth to genetic conditions.

"We are delighted to have secured this round of funding and the support of our investors," said Hassan Bennani, MD., CEO of KellBenx. "The funds will be used to launch an IRB-approved clinical trial and build our Long Island laboratory to analyze the data we are producing. We are excited about the prospects of our technology and the company going forward."

"We are extremely pleased to partner with such an esteemed group of investors," said Leonard H. Kellner, President of KellBenx. "All of our investors bring tremendous energy, intellect and resources to this partnership, and we plan on leveraging their extensive networks to accelerate the adoption of KellBenx' revolutionary technologies."

About KellBenx

Founded in 2010, KellBenx, Inc. is a privately-held biotechnology company based in New York City. KellBenx is developing high value, innovative tests that leverage the ability to extract clinically relevant information from blood.  Our focus is to improve women's healthcare and one of our first tests is in the area of non-invasive prenatal diagnosis (NIPD) for genetic disorders. For more information, please call 631.643.2614 or visit www.kellbenx.com.


'/>"/>
SOURCE KellBenx
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. KellBenx Secures Worldwide Agreement With Cedars-Sinai Medical Center for Biomarker Technology to Predict Premature Births
2. WNDM Secures Additional International Sales; $150 K in New Orders for 2011
3. BioNeutral Group Secures Three Initial Trial Orders for its Ogiene™ Odor Neutralizer & Multi-Purpose Cleaner Product Line
4. ACT Secures Patent to Generate Embryonic Stem Cells Without Embryo Destruction
5. Bacterin International Holdings Secures $5,000,000 Credit Facility with Bridge Bank
6. SeraCare Life Sciences Secures $20 Million Credit Facilities
7. Medizone International Secures $10,000,000 Funding Commitment
8. aTyr Pharma Secures $23M Financing From Top Tier Venture Investor
9. Omeros Secures $40 Million Committed Equity Financing Facility
10. SPO Medical Secures Agreement in Sleep Apnea Market
11. Biolaxy Secures IND Approval for Oral Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... They call it the “hairy ball.” ... depiction of a system of linkages and connections so complex and dense that ... computer science at Worcester Polytechnic Institute (WPI) and director of the university’s bioinformatics ...
(Date:10/12/2017)... ... ... AMRI, a global contract research, development and manufacturing organization ... quality of life, will now be offering its impurity solutions as a stand-alone ... for all new drug products, including the finalization of ICH M7 earlier this ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ComplianceOnline’s Medical Device ... on 7th and 8th June 2018 in San Francisco, CA. The Summit brings together ... as several distinguished CEOs, board directors and government officials from around the world to ...
(Date:10/11/2017)... Austin, TX (PRWEB) , ... October 11, 2017 ... ... in August compared the implantation and pregnancy rates in frozen and fresh ... the contribution of progesterone and maternal age to IVF success. , After comparing ...
Breaking Biology Technology:
(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017  IBM ... in dairy research, today announced a new collaboration using ... the chances that the global milk supply is impacted ... project, Cornell University has become the newest academic institution ... Chain, a food safety initiative that includes IBM Research, ...
(Date:5/23/2017)...  Hunova, the first robotic gym for the rehabilitation and functional motor ... Genoa, Italy . The first 30 robots will be ... USA . The technology was developed and patented at the ... spin-off Movendo Technology thanks to a 10 million euro investment from entrepreneur ... ...
(Date:5/16/2017)... , May 16, 2017   Bridge ... health organizations, and MD EMR Systems , ... development partner for GE, have established a partnership ... Portal product and the GE Centricity™ products, including ... EMR. These new integrations will ...
Breaking Biology News(10 mins):